Dustin Hammers is a board-certified clinical neuropsychologist and Associate Professor in the Department of Neurology at Indiana University (IU). Dr. Hammers is the lead neuropsychologist involved in the NIA-funded Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS), and he is currently the Principal Investigator on the NIA- and Alzheimer’s Association–funded study Lifestyle Interventions for the Treatment of Early-Onset AD Study (LITES). His research emphasizes the characterization of cognitive declines in Early-Onset AD, and the evaluation of diagnostic consistency between cognitive and advanced AD biomarkers (β-amyloid and tau) in an effort to improve diagnostic accuracy. Additional areas of interest include examining the assessment of cognitive change over time, teleneuropsychology and digital cognitive assessments, and the detection of early memory decline in elderly and dementia populations through computerized batteries and novel learning measures. He currently serves as Associate Editor of Alzheimer’s & Dementia: Diagnosis, Assessment, & Disease Monitoring, and has been the Guest Editor for a special issue from the Journal of Clinical and Experimental Neuropsychology. In addition to being the lead neuropsychologist for the multi-center NIA-funded Anti-NMDA Receptor Encephalitis ExTINGUISH trial, he serves on the Global CEO Initiative on Alzheimer’s Disease Work Group on appropriate use criteria for digital cognitive assessments. Finally, he is the past Chair of the American Psychological Association’s (APA) Committee on Rural Health, and is currently a Liaison for the Public Interest Advisory Committee, APA Society for Clinical Neuropsychology.
